Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. - Wikidata - wikimedia - TriplyDB

Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.

Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.

http://www.wikidata.org/entity/Q37116400

about

Clinical and microbiological diagnosis of oral candidiasis Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.The mouth: a gateway or a trap for HIV?Expression QTL mapping in regulatory and helper T cells from the BXD family of strains reveals novel cell-specific genes, gene-gene interactions and candidate genes for auto-immune disease.Oropharyngeal Candida colonization in human immunodeficiency virus infected patients.Aberrant host defense against Leishmania major in the absence of SLPI.Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus.New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.Systemic and mucosal differences in HIV burden, immune, and therapeutic responses Alcohol and tobacco consumption affect the oral carriage of Candida albicans and mutans streptococci.Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.The impact of cigarette/tobacco smoking on oral candidosis: an overview.Smoking as a risk factor for oral candidiasis in HIV-infected adults.Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals.Fungal proteases and their pathophysiological effects.Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.Volatile organic compounds in the breath of oral candidiasis patients: a pilot study.Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases.Identification of signature volatiles to discriminate Candida albicans, glabrata, krusei and tropicalis using gas chromatography and mass spectrometry.Houttuynia cordata modulates oral innate immune mediators: potential role of herbal plant on oral health.Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris.

P2860

Q26822250-CECCB91E-D97F-4730-AE67-277B9C44980C Q33715960-033DD970-8DF1-4BBE-B9BF-35BAB0AA41F1 Q33874252-ED431777-869B-426C-9DE5-A5566517AC85 Q34105794-A1714F79-8C7B-4C16-9973-C7C3BB35E055 Q34303424-A3CDC64E-C25E-4DFF-A101-84FA9882F055 Q34341332-899C2938-7B7F-4A9C-97E8-08FF75F537B6 Q34982574-A1A990F8-4D10-4CDB-9653-2517484C2DE0 Q35057902-2B2735B5-E561-4630-8B2A-E04EFA84EAA1 Q35190200-39C360B1-E3FF-47D1-A1E5-90F4A7177FF5 Q36083866-33573706-4731-4939-9CB2-6DCCDA7D944A Q36114167-FC92249B-75BB-4830-8E2C-8B8F2BF9D96C Q36239683-FB74AF1B-FF04-41C3-B2D4-5DB52AB1A792 Q36672771-A851541B-3ABE-4CC6-B7C3-C5FED4E07F83 Q36898823-669FF311-F48C-46DE-B955-68E71E074D57 Q37596710-587A9857-FC3A-4685-B3C6-24D85B39486A Q37831836-2398956D-FB7B-4BE6-AB46-CBDFF550754D Q39547383-AE319BFE-224E-47C1-B15E-1FE683921F3B Q40177721-636157F3-59CB-4CEA-A2AD-29DA074BB08D Q40242898-1196D5A0-CCEE-4C67-8E4E-A404C38D79E1 Q40871352-D84AA15A-16FB-4267-ADEF-1F366BC059B2 Q41561850-2111DACF-7DCB-4079-938F-8CF86C003D9D Q42575864-95F47053-796A-468C-A095-6F36D5D2004E

P2860

Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.

http://www.wikidata.org/entity/Q37116400

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Salivary secretory leukocyte p ...... virus type 1-infected persons.

@en

Salivary secretory leukocyte p ...... virus type 1-infected persons.

@nl

type

label

Salivary secretory leukocyte p ...... virus type 1-infected persons.

@en

Salivary secretory leukocyte p ...... virus type 1-infected persons.

@nl

prefLabel

Salivary secretory leukocyte p ...... virus type 1-infected persons.

@en

Salivary secretory leukocyte p ...... virus type 1-infected persons.

@nl

P1433

Q37116400-6614FC49-109B-4B27-B40D-D96CBDA601F7

P1476

Q37116400-5B9A1665-C2CD-449B-995A-3A44A8ED4692

P2093

Q37116400-35416DA9-2578-42A8-8120-2B370868D45D

Q37116400-35DC1C44-A92F-4E31-9289-089E4F84D1AC

Q37116400-3BF0BE8B-9C5F-4E2B-A755-6511FDB5FB66

Q37116400-9BED3AE2-00A3-47DF-8C25-1CBC6AF4D6E3

Q37116400-B56E006D-224E-46A6-9CBA-F1A336BAC682

Q37116400-C7658514-081C-4892-A605-C81AE8CFA5A4

Q37116400-F6263737-AA7B-4202-8BD5-C11AB030CAB6

P2860

Q37116400-101F8343-7C42-4AEF-B0F0-95D3EA1D101C

Q37116400-1200B704-318A-4AB1-A475-284872AA84E6

Q37116400-17F35D16-19F7-4ED0-86DF-FDC85DCEE6AD

Q37116400-181FCF2D-FA2C-4C7C-A73B-CA968B3AE142

Q37116400-1DE898BC-DA52-4936-B204-1AE056B00679

Q37116400-2289405C-FEC2-40BC-8656-7B96AFA8B9A9

Q37116400-34C16978-BE17-47BD-B2B7-2CEDC9128D85

Q37116400-34FFFC61-4FE8-426A-9B14-E214FDD10034

Q37116400-3DEEA542-D96C-4C3B-ABB1-FF3E52AE9B91

Q37116400-48BCBDE3-9063-42C3-97EC-BEDC1A83EFA0

P304

Q37116400-EE542988-856D-4A64-B373-B7ADD977D7C8

P31

Q37116400-AF32D90F-DAF5-44CE-83E3-DFDC299D08AD

P356

Q37116400-B8BED30E-01E1-4165-8882-F585B3E89173

P407

Q37116400-C24335A6-C594-4C4D-AD7C-D545D38049D6

P433

Q37116400-682B9131-ECDE-4BEE-9DEE-F3ECC263E148

P478

Q37116400-90E0CEB5-3033-4663-9CA4-729CA5D2FB98

P577

Q37116400-A7956081-EA76-469C-9F64-3B0BBECDEF87

P5875

Q37116400-1E8135CF-06B3-477B-82AE-1234994A9E58

P698

Q37116400-B23FC83A-9493-4C90-B071-BDB5D3734FE6

P932

Q37116400-EC3521DF-03C3-4208-8F29-60F1BC4991A8

P356

IAI.72.4.1956-1963.2004

P1433

Infection and Immunity

P1476

Salivary secretory leukocyte p ...... virus type 1-infected persons.

@en

P2093

Amit Chattopadhyay

http://www.w3.org/2001/XMLSchema#string

Daniel J Caplan

http://www.w3.org/2001/XMLSchema#string

Diane C Shugars

http://www.w3.org/2001/XMLSchema#string

Gary D Slade

http://www.w3.org/2001/XMLSchema#string

Hsaio-Chuan Tien

http://www.w3.org/2001/XMLSchema#string

Lauren L Patton

http://www.w3.org/2001/XMLSchema#string

Laurie R Gray

http://www.w3.org/2001/XMLSchema#string

P2860

The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

Location of the protease-inhibitory region of secretory leukocyte protease inhibitor

Endogenous salivary inhibitors of human immunodeficiency virus.

Viral and fungal infections of the oral cavity in immunocompetent patients.

Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.

Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization.

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.

P304

1956-1963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.72.4.1956-1963.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8662069

http://www.w3.org/2001/XMLSchema#string

P698

15039315

http://www.w3.org/2001/XMLSchema#string

P932

375171

http://www.w3.org/2001/XMLSchema#string